Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- PMID: 21423189
- DOI: 10.1038/nbt.1807
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Abstract
To realize the therapeutic potential of RNA drugs, efficient, tissue-specific and nonimmunogenic delivery technologies must be developed. Here we show that exosomes-endogenous nano-vesicles that transport RNAs and proteins-can deliver short interfering (si)RNA to the brain in mice. To reduce immunogenicity, we used self-derived dendritic cells for exosome production. Targeting was achieved by engineering the dendritic cells to express Lamp2b, an exosomal membrane protein, fused to the neuron-specific RVG peptide. Purified exosomes were loaded with exogenous siRNA by electroporation. Intravenously injected RVG-targeted exosomes delivered GAPDH siRNA specifically to neurons, microglia, oligodendrocytes in the brain, resulting in a specific gene knockdown. Pre-exposure to RVG exosomes did not attenuate knockdown, and non-specific uptake in other tissues was not observed. The therapeutic potential of exosome-mediated siRNA delivery was demonstrated by the strong mRNA (60%) and protein (62%) knockdown of BACE1, a therapeutic target in Alzheimer's disease, in wild-type mice.
Comment in
-
SiRNA delivery with exosome nanoparticles.Nat Biotechnol. 2011 Apr;29(4):325-6. doi: 10.1038/nbt.1830. Nat Biotechnol. 2011. PMID: 21478846 No abstract available.
-
Getting RNAi therapies to the brain.Nat Rev Genet. 2011 May;12(5):296. doi: 10.1038/nrg2990. Nat Rev Genet. 2011. PMID: 21499291 No abstract available.
-
A new endogenous and immunologically inert siRNA delivery vehicle for targeting the brain.Nanomedicine (Lond). 2011 Sep;6(7):1157-8. Nanomedicine (Lond). 2011. PMID: 22029061 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials